Wednesday, April 7, 2010 as of 11:14 AM ET
Wyeth, formerly one of the companies owned by American Home Products Corporation (AHP), was a pharmaceutical company.
Read More at Wikipedia ›Pfizer Inc.
(PFE) said its Pristiq extended-release antidepressant showed positive results in a long-term study of adults when compared with a placebo.The pharmaceutical giant said the latest results--presented at Annual Meeting of the American Psychiatric Association--and a study of peri- and post-menopausal added to data supporting Pristiq's effectiveness and safety.Pfizer and other drug makers have been aiming to improve their pipelines and expand uses of older drugs as the industry deals with a patent cliff. Pfizer's blockbuster anticholesterol drug Lipitor lost U.S. marketing exclusively in November, leading to weaker results in recent quarters.In a long term study, patients that received 50 milligrams a day of Pristiq showed a relapse probability of 14.3% compared with 30.2% for the group taking a placebo at month six.The drug also showed statistically significant reductions in depression symptoms in an eight week study of peri- and postmenopausal women, compared with a placebo.A...Pfizer Inc on Monday said it had acquired privately held Alacer Corp, the largest U.S. maker of vitamin C products, bolstering Pfizer's array of vitamin brands and i...
A federal court ruled that stents marketed by Boston Scientific Corp. (BSX), Abbott Laboratories (ABT), and Medtronic Inc. (MDT) don't infringe on Johnson & Johnson ...
Corelogic Chief Economist Mark Fleming, George Mason University’s Anthony Sanders and Fmr. Fannie Mae E.V.P. Ed Pinto on the downturn in the housing market.
Pfizer (NYSE:PFE) weighed in on Tuesday by posting a 5.5% rise in second-quarter profits as the drug behemoth benefited from sales of animal products pharmaceuticals...
Pfizer Inc.'s (PFE) second-quarter earnings rose 5.5% amid fewer acquisition-related charges as the pharmaceutical giant also benefited from a lower tax rate.The wor...
Morgan Stanley Smith Barney Chief Investment Strategist David Darst on why the economy and markets are facing a soft patch, but not a full-fledged double-dip recession.
By Ransdell PiersonNEW YORK (Reuters) - Pfizer Inc is expected to report slightly lower quarterly earnings on Tuesday, but investors will be more focused on any sign...
Five major companies joined the FOX50 index on Tuesday, highlighted by American icons Ford (NYSE:F) and JPMorgan Chase (NYSE:JPM), each of which managed to excel in ...
Five new companies have been added to the FOX50, FOX Business Network's index of the 50 top American brands. Fox Business launched the FOX50 in October 2007 upon the...
By James Regan and Quentin WebbPARIS/LONDON (Reuters) - Sanofi-Aventis SA <SASY.PA> and Merck & Co Inc <MRK.N> on Tuesday abandoned plans for a joint animal health v...
Pfizer 's President and CEO Jeffrey Kindler unexpectedly resigned his post, the company said in a statement late Sunday, ending his 4-1/2 year tenure as head of the ...
Pfizer Inc (NYSE:PFE) reported sales far below Wall Street forecasts on Tuesday, hurt by a stronger dollar, generic competition internationally for cholesterol drug ...
DOW JONES NEWSWIRESPfizer Inc.'s (PFE) first-quarter earnings fell 19% as the pharmaceutical giant reported its first full quarter since its blockbuster cholesterol ...
Pfizer Inc.'s (PFE) earnings could get a boost in coming years if the drug maker uses most of the proceeds from the sale of its nutrition business for share buybacks...
Pfizer Inc. (PFE) will soon shift certain U.S. promotional responsibilities for the blockbuster anti-inflammatory drug Enbrel to its marketing partner, Amgen Inc. (A...
Nestle is reportedly closing in on a deal to buy Pfizer's (NYSE:PFE) infant nutrition business, a win that would give it a market advantage in both China and the Asi...
Pfizer Inc (NYSE:PFE) said Chief Executive Ian Read's compensation jumped more than 40 percent last year to $25 million as he steered a steady course for the world's...
Rivals Nestle and Danone-Mead Johnson will battle for Pfizer ’s (NYSE:PFE) $10 billion infant nutrition business next week, though the Swiss giant has already been p...
Pfizer Inc. (PFE) has withdrawn an application seeking U.S. regulatory approval to market its antidepressant Pristiq as a treatment for certain menopause-related sym...
Quotes delayed at least 15 minutes. Real-time quotes provided by BATS Exchange. Market Data provided by Interactive Data (Terms & Conditions). Powered and Implemented by Interactive Data Managed Solutions. Company fundamental data provided by Morningstar. Earnings estimates data provided by Zacks. Mutual fund data provided by Lipper. Economic data provided by Econoday. Dow Jones & Company Terms & Conditions.
This material may not be published, broadcast, rewritten, or redistributed. ©2012 FOX News Network, LLC. All rights reserved.
